Profit Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,306
| Closed | -$323K | – | 79 |
|
|
2023
Q4 | $323K | Hold |
10,306
| – | – | 0.18% | 75 |
|
|
2023
Q3 | $215K | Sell |
10,306
-523
| -5% | -$10.9K | 0.15% | 72 |
|
|
2023
Q2 | $259K | Sell |
10,829
-179
| -2% | -$4.29K | 0.17% | 73 |
|
|
2023
Q1 | $207K | Hold |
11,008
| – | – | 0.14% | 75 |
|
|
2022
Q4 | $175K | Hold |
11,008
| – | – | 0.12% | 75 |
|
|
2022
Q3 | $180K | Hold |
11,008
| – | – | 0.14% | 77 |
|
|
2022
Q2 | $155K | Sell |
11,008
-2,508
| -19% | -$35.3K | 0.11% | 78 |
|
|
2022
Q1 | $328K | Buy |
13,516
+1,844
| +16% | +$44.7K | 0.2% | 74 |
|
|
2021
Q4 | $273K | Sell |
11,672
-500
| -4% | -$11.7K | 0.17% | 79 |
|
|
2021
Q3 | $203K | Hold |
12,172
| – | – | 0.14% | 86 |
|
|
2021
Q2 | $295K | Hold |
12,172
| – | – | 0.16% | 81 |
|
|
2021
Q1 | $314K | Hold |
12,172
| – | – | 0.18% | 78 |
|
|
2020
Q4 | $651K | Sell |
12,172
-9,749
| -44% | -$521K | 0.42% | 49 |
|
|
2020
Q3 | $905K | Buy |
+21,921
| New | +$905K | 0.56% | 64 |
|